SUPN Supernus Pharmaceuticals
- 33.970
- -0.100-0.29%
Supernus Pharmaceuticals News
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
No Data